{
  "DOI": "10.1038/ejhg.2008.162",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2008.162",
  "alternative-id": [
    "BFejhg2008162"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Blumenthal",
      "given": "Gideon M",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Dennis",
      "given": "Phillip A",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2008,
        9,
        10
      ]
    ],
    "date-time": "2008-09-10T10:27:02Z",
    "timestamp": 1221042422000
  },
  "deposited": {
    "date-parts": [
      [
        2024,
        2,
        29
      ]
    ],
    "date-time": "2024-02-29T18:12:15Z",
    "timestamp": 1709230335000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        16
      ]
    ],
    "date-time": "2024-04-16T09:09:03Z",
    "timestamp": 1713258543051
  },
  "is-referenced-by-count": 207,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "11",
  "issued": {
    "date-parts": [
      [
        2008,
        9,
        10
      ]
    ]
  },
  "journal-issue": {
    "issue": "11",
    "published-print": {
      "date-parts": [
        [
          2008,
          11
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2008,
            9,
            10
          ]
        ],
        "date-time": "2008-09-10T00:00:00Z",
        "timestamp": 1221004800000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2008162.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2008162",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2008162.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1289-1300",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2008,
        9,
        10
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2008,
        9,
        10
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2008,
        11
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1136/jmg.37.11.828",
      "author": "C Eng",
      "doi-asserted-by": "publisher",
      "first-page": "828",
      "journal-title": "J Med Genet",
      "key": "BFejhg2008162_CR1",
      "unstructured": "Eng C : Will the real Cowden syndrome please stand up: revised diagnostic criteria. J Med Genet 2000; 37: 828–830.",
      "volume": "37",
      "year": "2000"
    },
    {
      "DOI": "10.1093/hmg/7.3.507",
      "author": "DJ Marsh",
      "doi-asserted-by": "publisher",
      "first-page": "507",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2008162_CR2",
      "unstructured": "Marsh DJ, Coulon V, Lunetta KL et al: Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998; 7: 507–515.",
      "volume": "7",
      "year": "1998"
    },
    {
      "DOI": "10.1002/humu.10257",
      "author": "C Eng",
      "doi-asserted-by": "publisher",
      "first-page": "183",
      "journal-title": "Hum Mutat",
      "key": "BFejhg2008162_CR3",
      "unstructured": "Eng C : PTEN: one gene, many syndromes. Hum Mutat 2003; 22: 183–198.",
      "volume": "22",
      "year": "2003"
    },
    {
      "DOI": "10.1126/science.280.5369.1614",
      "author": "M Tamura",
      "doi-asserted-by": "publisher",
      "first-page": "1614",
      "journal-title": "Science",
      "key": "BFejhg2008162_CR4",
      "unstructured": "Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM : Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 1998; 280: 1614–1617.",
      "volume": "280",
      "year": "1998"
    },
    {
      "DOI": "10.1006/excr.2000.5130",
      "author": "L Simpson",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Exp Cell Res",
      "key": "BFejhg2008162_CR5",
      "unstructured": "Simpson L, Parsons R : PTEN: life as a tumor suppressor. Exp Cell Res 2001; 264: 29–41.",
      "volume": "264",
      "year": "2001"
    },
    {
      "DOI": "10.1093/hmg/10.6.605",
      "author": "LP Weng",
      "doi-asserted-by": "publisher",
      "first-page": "605",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2008162_CR6",
      "unstructured": "Weng LP, Smith WM, Brown JL, Eng C : PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum Mol Genet 2001; 10: 605–616.",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.cell.2006.11.042",
      "author": "WH Shen",
      "doi-asserted-by": "publisher",
      "first-page": "157",
      "journal-title": "Cell",
      "key": "BFejhg2008162_CR7",
      "unstructured": "Shen WH, Balajee AS, Wang J et al: Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 2007; 128: 157–170.",
      "volume": "128",
      "year": "2007"
    },
    {
      "DOI": "10.1038/1235",
      "author": "A Di Cristofano",
      "doi-asserted-by": "publisher",
      "first-page": "348",
      "journal-title": "Nat Genet",
      "key": "BFejhg2008162_CR8",
      "unstructured": "Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP : Pten is essential for embryonic development and tumour suppression. Nat Genet 1998; 19: 348–355.",
      "volume": "19",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S0960-9822(07)00488-5",
      "author": "A Suzuki",
      "doi-asserted-by": "publisher",
      "first-page": "1169",
      "journal-title": "Curr Biol",
      "key": "BFejhg2008162_CR9",
      "unstructured": "Suzuki A, de la Pompa JL, Stambolic V et al: High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 1998; 8: 1169–1178.",
      "volume": "8",
      "year": "1998"
    },
    {
      "DOI": "10.1073/pnas.96.4.1563",
      "author": "K Podsypanina",
      "doi-asserted-by": "publisher",
      "first-page": "1563",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2008162_CR10",
      "unstructured": "Podsypanina K, Ellenson LH, Nemes A et al: Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 1999; 96: 1563–1568.",
      "volume": "96",
      "year": "1999"
    },
    {
      "DOI": "10.1073/pnas.94.23.12479",
      "author": "FB Furnari",
      "doi-asserted-by": "publisher",
      "first-page": "12479",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2008162_CR11",
      "unstructured": "Furnari FB, Lin H, Huang HS, Cavenee WK : Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 1997; 94: 12479–12484.",
      "volume": "94",
      "year": "1997"
    },
    {
      "author": "MA Davies",
      "first-page": "1904",
      "journal-title": "Clin Cancer Res",
      "key": "BFejhg2008162_CR12",
      "unstructured": "Davies MA, Kim SJ, Parikh NU, Dong Z, Bucana CD, Gallick GE : Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. Clin Cancer Res 2002; 8: 1904–1914.",
      "volume": "8",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0092-8674(00)81780-8",
      "author": "V Stambolic",
      "doi-asserted-by": "publisher",
      "first-page": "29",
      "journal-title": "Cell",
      "key": "BFejhg2008162_CR13",
      "unstructured": "Stambolic V, Suzuki A, de la Pompa JL et al: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 1998; 95: 29–39.",
      "volume": "95",
      "year": "1998"
    },
    {
      "DOI": "10.7326/0003-4819-58-1-136",
      "author": "KM Lloyd II",
      "doi-asserted-by": "publisher",
      "first-page": "136",
      "journal-title": "Ann Intern Med",
      "key": "BFejhg2008162_CR14",
      "unstructured": "Lloyd II KM, Dennis M : Cowden's disease. A possible new symptom complex with multiple system involvement. Ann Intern Med 1963; 58: 136–142.",
      "volume": "58",
      "year": "1963"
    },
    {
      "DOI": "10.1038/ng0597-64",
      "author": "D Liaw",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "journal-title": "Nat Genet",
      "key": "BFejhg2008162_CR15",
      "unstructured": "Liaw D, Marsh DJ, Li J et al: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997; 16: 64–67.",
      "volume": "16",
      "year": "1997"
    },
    {
      "DOI": "10.1111/j.1399-0004.1986.tb00816.x",
      "author": "TM Starink",
      "doi-asserted-by": "publisher",
      "first-page": "222",
      "journal-title": "Clin Genet",
      "key": "BFejhg2008162_CR16",
      "unstructured": "Starink TM, van der Veen JP, Arwert F et al: The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986; 29: 222–233.",
      "volume": "29",
      "year": "1986"
    },
    {
      "DOI": "10.1111/j.1572-0241.2003.07496.x",
      "author": "TJ McGarrity",
      "doi-asserted-by": "publisher",
      "first-page": "1429",
      "journal-title": "Am J Gastroenterol",
      "key": "BFejhg2008162_CR17",
      "unstructured": "McGarrity TJ, Wagner Baker MJ, Ruggiero FM et al: GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations. Am J Gastroenterol 2003; 98: 1429–1434.",
      "volume": "98",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S1092-9134(99)80011-2",
      "author": "HR Harach",
      "doi-asserted-by": "publisher",
      "first-page": "331",
      "journal-title": "Ann Diagn Pathol",
      "key": "BFejhg2008162_CR18",
      "unstructured": "Harach HR, Soubeyran I, Brown A, Bonneau D, Longy M : Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 1999; 3: 331–340.",
      "volume": "3",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0046-8177(98)90389-6",
      "author": "CA Schrager",
      "doi-asserted-by": "publisher",
      "first-page": "47",
      "journal-title": "Hum Pathol",
      "key": "BFejhg2008162_CR19",
      "unstructured": "Schrager CA, Schneider D, Gruener AC, Tsou HC, Peacocke M : Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer. Hum Pathol 1998; 29: 47–53.",
      "volume": "29",
      "year": "1998"
    },
    {
      "DOI": "10.1053/j.seminoncol.2007.07.009",
      "author": "S Gustafson",
      "doi-asserted-by": "publisher",
      "first-page": "428",
      "journal-title": "Semin Oncol",
      "key": "BFejhg2008162_CR20",
      "unstructured": "Gustafson S, Zbuk KM, Scacheri C, Eng C : Cowden syndrome. Semin Oncol 2007; 34: 428–434.",
      "volume": "34",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jmg.2007.048934",
      "author": "WH Tan",
      "doi-asserted-by": "publisher",
      "first-page": "594",
      "journal-title": "J Med Genet",
      "key": "BFejhg2008162_CR21",
      "unstructured": "Tan WH, Baris HN, Burrows PE et al: The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet 2007; 44: 594–602.",
      "volume": "44",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jmg.2007.049981",
      "author": "KL Lachlan",
      "doi-asserted-by": "publisher",
      "first-page": "579",
      "journal-title": "J Med Genet",
      "key": "BFejhg2008162_CR22",
      "unstructured": "Lachlan KL, Lucassen AM, Bunyan D, Temple IK : Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet 2007; 44: 579–585.",
      "volume": "44",
      "year": "2007"
    },
    {
      "author": "M Longy",
      "first-page": "35",
      "journal-title": "Ann Genet",
      "key": "BFejhg2008162_CR23",
      "unstructured": "Longy M, Lacombe D : Cowden disease. Report of a family and review. Ann Genet 1996; 39: 35–42.",
      "volume": "39",
      "year": "1996"
    },
    {
      "DOI": "10.3233/BD-2007-27103",
      "author": "R Nusbaum",
      "doi-asserted-by": "publisher",
      "first-page": "21",
      "journal-title": "Breast Dis",
      "key": "BFejhg2008162_CR24",
      "unstructured": "Nusbaum R, Vogel KJ, Ready K : Susceptibility to breast cancer: hereditary syndromes and low penetrance genes. Breast Dis 2006; 27: 21–50.",
      "volume": "27",
      "year": "2006"
    },
    {
      "DOI": "10.1136/jmg.38.3.159",
      "author": "JD Fackenthal",
      "doi-asserted-by": "publisher",
      "first-page": "159",
      "journal-title": "J Med Genet",
      "key": "BFejhg2008162_CR25",
      "unstructured": "Fackenthal JD, Marsh DJ, Richardson AL et al: Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 2001; 38: 159–164.",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1136/jmg.2004.018036",
      "author": "R Pilarski",
      "doi-asserted-by": "publisher",
      "first-page": "323",
      "journal-title": "J Med Genet",
      "key": "BFejhg2008162_CR26",
      "unstructured": "Pilarski R, Eng C : Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 2004; 41: 323–326.",
      "volume": "41",
      "year": "2004"
    },
    {
      "DOI": "10.1093/hmg/8.8.1461",
      "author": "DJ Marsh",
      "doi-asserted-by": "publisher",
      "first-page": "1461",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2008162_CR27",
      "unstructured": "Marsh DJ, Kum JB, Lunetta KL et al: PTEN mutation spectrum and genotype–phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet 1999; 8: 1461–1472.",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.1086/377109",
      "author": "XP Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "404",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2008162_CR28",
      "unstructured": "Zhou XP, Waite KA, Pilarski R et al: Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 2003; 73: 404–411.",
      "volume": "73",
      "year": "2003"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-07-2488",
      "author": "H Yang",
      "doi-asserted-by": "publisher",
      "first-page": "425",
      "journal-title": "Cancer Res",
      "key": "BFejhg2008162_CR29",
      "unstructured": "Yang H, Kong W, He L et al: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008; 68: 425–433.",
      "volume": "68",
      "year": "2008"
    },
    {
      "DOI": "10.1016/j.cell.2006.11.040",
      "author": "LC Trotman",
      "doi-asserted-by": "publisher",
      "first-page": "141",
      "journal-title": "Cell",
      "key": "BFejhg2008162_CR30",
      "unstructured": "Trotman LC, Wang X, Alimonti A et al: Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007; 128: 141–156.",
      "volume": "128",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.cell.2006.11.039",
      "author": "X Wang",
      "doi-asserted-by": "publisher",
      "first-page": "129",
      "journal-title": "Cell",
      "key": "BFejhg2008162_CR31",
      "unstructured": "Wang X, Trotman LC, Koppie T et al: NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 2007; 128: 129–139.",
      "volume": "128",
      "year": "2007"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-06-0384",
      "author": "A Mirmohammadsadegh",
      "doi-asserted-by": "publisher",
      "first-page": "6546",
      "journal-title": "Cancer Res",
      "key": "BFejhg2008162_CR32",
      "unstructured": "Mirmohammadsadegh A, Marini A, Nambiar S et al: Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 2006; 66: 6546–6552.",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1086/504392",
      "author": "MS Sarquis",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2008162_CR33",
      "unstructured": "Sarquis MS, Agrawal S, Shen L, Pilarski R, Zhou XP, Eng C : Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Hum Genet 2006; 79: 23–30.",
      "volume": "79",
      "year": "2006"
    },
    {
      "DOI": "10.1093/hmg/ddi492",
      "author": "S Agrawal",
      "doi-asserted-by": "publisher",
      "first-page": "777",
      "journal-title": "Hum Mol Genet",
      "key": "BFejhg2008162_CR34",
      "unstructured": "Agrawal S, Eng C : Differential expression of novel naturally occurring splice variants of PTEN and their functional consequences in Cowden syndrome and sporadic breast cancer. Hum Mol Genet 2006; 15: 777–787.",
      "volume": "15",
      "year": "2006"
    },
    {
      "DOI": "10.1038/nrc2037",
      "author": "KM Zbuk",
      "doi-asserted-by": "publisher",
      "first-page": "35",
      "journal-title": "Nat Rev Cancer",
      "key": "BFejhg2008162_CR35",
      "unstructured": "Zbuk KM, Eng C : Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer 2007; 7: 35–45.",
      "volume": "7",
      "year": "2007"
    },
    {
      "DOI": "10.1086/379382",
      "author": "XP Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "1191",
      "journal-title": "Am J Hum Genet",
      "key": "BFejhg2008162_CR36",
      "unstructured": "Zhou XP, Marsh DJ, Morrison CD et al: Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte–Duclos disease in adults. Am J Hum Genet 2003; 73: 1191–1198.",
      "volume": "73",
      "year": "2003"
    },
    {
      "author": "DW Williams III",
      "first-page": "287",
      "journal-title": "AJNR Am J Neuroradiol",
      "key": "BFejhg2008162_CR37",
      "unstructured": "Williams III DW, Elster AD, Ginsberg LE, Stanton C : Recurrent Lhermitte–Duclos disease: report of two cases and association with Cowden's disease. AJNR Am J Neuroradiol 1992; 13: 287–290.",
      "volume": "13",
      "year": "1992"
    },
    {
      "DOI": "10.1093/jnen/64.4.341",
      "author": "TW Abel",
      "doi-asserted-by": "publisher",
      "first-page": "341",
      "journal-title": "J Neuropathol Exp Neurol",
      "key": "BFejhg2008162_CR38",
      "unstructured": "Abel TW, Baker SJ, Fraser MM et al: Lhermitte–Duclos disease: a report of 31 cases with immunohistochemical analysis of the PTEN/AKT/mTOR pathway. J Neuropathol Exp Neurol 2005; 64: 341–349.",
      "volume": "64",
      "year": "2005"
    },
    {
      "author": "GA Bannayan",
      "first-page": "1",
      "journal-title": "Arch Pathol",
      "key": "BFejhg2008162_CR39",
      "unstructured": "Bannayan GA : Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome. Arch Pathol 1971; 92: 1–5.",
      "volume": "92",
      "year": "1971"
    },
    {
      "DOI": "10.1002/ajmg.1320340419",
      "author": "D Moretti-Ferreira",
      "doi-asserted-by": "publisher",
      "first-page": "548",
      "journal-title": "Am J Med Genet",
      "key": "BFejhg2008162_CR40",
      "unstructured": "Moretti-Ferreira D, Koiffmann CP, Souza DH, Diament AJ, Wajntal A : Macrocephaly, multiple lipomas, and hemangiomata (Bannayan-Zonana syndrome): genetic heterogeneity or autosomal dominant locus with at least two different allelic forms? Am J Med Genet 1989; 34: 548–551.",
      "volume": "34",
      "year": "1989"
    },
    {
      "DOI": "10.1002/ajmg.1320190204",
      "author": "JH Miles",
      "doi-asserted-by": "publisher",
      "first-page": "225",
      "journal-title": "Am J Med Genet",
      "key": "BFejhg2008162_CR41",
      "unstructured": "Miles JH, Zonana J, McFarlane J, Aleck KA, Bawle E : Macrocephaly with hamartomas: Bannayan-Zonana syndrome. Am J Med Genet 1984; 19: 225–234.",
      "volume": "19",
      "year": "1984"
    },
    {
      "DOI": "10.1016/S0022-3468(05)80100-9",
      "author": "Y Hayashi",
      "doi-asserted-by": "publisher",
      "first-page": "722",
      "journal-title": "J Pediatr Surg",
      "key": "BFejhg2008162_CR42",
      "unstructured": "Hayashi Y, Ohi R, Tomita Y, Chiba T, Matsumoto Y : Bannayan-Zonana syndrome associated with lipomas, hemangiomas, and lymphangiomas. J Pediatr Surg 1992; 27: 722–723.",
      "volume": "27",
      "year": "1992"
    },
    {
      "DOI": "10.1136/jmg.38.1.52",
      "author": "MA Parisi",
      "doi-asserted-by": "publisher",
      "first-page": "52",
      "journal-title": "J Med Genet",
      "key": "BFejhg2008162_CR43",
      "unstructured": "Parisi MA, Dinulos MB, Leppig KA, Sybert VP, Eng C, Hudgins L : The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. J Med Genet 2001; 38: 52–58.",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1007/BF00661895",
      "author": "HR Wiedemann",
      "doi-asserted-by": "publisher",
      "first-page": "5",
      "journal-title": "Eur J Pediatr",
      "key": "BFejhg2008162_CR44",
      "unstructured": "Wiedemann HR, Burgio GR, Aldenhoff P, Kunze J, Kaufmann HJ, Schirg E : The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr 1983; 140: 5–12.",
      "volume": "140",
      "year": "1983"
    },
    {
      "DOI": "10.1002/ajmg.c.30063",
      "author": "MM Cohen",
      "doi-asserted-by": "publisher",
      "first-page": "38",
      "journal-title": "Am J Med Genet C Semin Med Genet",
      "key": "BFejhg2008162_CR45",
      "unstructured": "Cohen MM, Jr : Proteus syndrome: an update. Am J Med Genet C Semin Med Genet 2005; 137: 38–52.",
      "volume": "137",
      "year": "2005"
    },
    {
      "DOI": "10.1002/ajmg.a.20474",
      "author": "MM Cohen Jr",
      "doi-asserted-by": "publisher",
      "first-page": "323",
      "journal-title": "Am J Med Genet A",
      "key": "BFejhg2008162_CR46",
      "unstructured": "Cohen Jr MM, Turner JT, Biesecker LG : Proteus syndrome: misdiagnosis with PTEN mutations. Am J Med Genet A 2003; 122: 323–324.",
      "volume": "122",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0140-6736(01)05412-5",
      "author": "X Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "210",
      "journal-title": "Lancet",
      "key": "BFejhg2008162_CR47",
      "unstructured": "Zhou X, Hampel H, Thiele H et al: Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet 2001; 358: 210–211.",
      "volume": "358",
      "year": "2001"
    },
    {
      "DOI": "10.1136/jmg.39.12.937",
      "author": "JM Smith",
      "doi-asserted-by": "publisher",
      "first-page": "937",
      "journal-title": "J Med Genet",
      "key": "BFejhg2008162_CR48",
      "unstructured": "Smith JM, Kirk EP, Theodosopoulos G et al: Germline mutation of the tumour suppressor PTEN in Proteus syndrome. J Med Genet 2002; 39: 937–940.",
      "volume": "39",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0140-6736(01)07109-4",
      "author": "LG Biesecker",
      "doi-asserted-by": "publisher",
      "first-page": "2079",
      "journal-title": "Lancet",
      "key": "BFejhg2008162_CR49",
      "unstructured": "Biesecker LG, Rosenberg MJ, Vacha S, Turner JT, Cohen MM : PTEN mutations and proteus syndrome. Lancet 2001; 358: 2079–2080.",
      "volume": "358",
      "year": "2001"
    },
    {
      "DOI": "10.1002/ajmg.a.30335",
      "author": "I Thiffault",
      "doi-asserted-by": "publisher",
      "first-page": "123",
      "journal-title": "Am J Med Genet A",
      "key": "BFejhg2008162_CR50",
      "unstructured": "Thiffault I, Schwartz CE, Der Kaloustian V, Foulkes WD : Mutation analysis of the tumor suppressor PTEN and the glypican 3 (GPC3) gene in patients diagnosed with Proteus syndrome. Am J Med Genet A 2004; 130: 123–127.",
      "volume": "130",
      "year": "2004"
    },
    {
      "DOI": "10.1111/j.1365-2133.2007.07818.x",
      "author": "R Happle",
      "doi-asserted-by": "publisher",
      "first-page": "1089",
      "journal-title": "Br J Dermatol",
      "key": "BFejhg2008162_CR51",
      "unstructured": "Happle R : Type 2 segmental Cowden disease vs Proteus syndrome. Br J Dermatol 2007; 156: 1089–1090.",
      "volume": "156",
      "year": "2007"
    },
    {
      "author": "R Happle",
      "first-page": "133",
      "journal-title": "Eur J Dermatol",
      "key": "BFejhg2008162_CR52",
      "unstructured": "Happle R : Linear Cowden nevus: a new distinct epidermal nevus. Eur J Dermatol 2007; 17: 133–136.",
      "volume": "17",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.ejhg.5201823",
      "author": "F Caux",
      "doi-asserted-by": "publisher",
      "first-page": "767",
      "journal-title": "Eur J Hum Genet",
      "key": "BFejhg2008162_CR53",
      "unstructured": "Caux F, Plauchu H, Chibon F et al: Segmental overgrowth, lipomatosis, arteriovenous malformation and epidermal nevus (SOLAMEN) syndrome is related to mosaic PTEN nullizygosity. Eur J Hum Genet 2007; 15: 767–773.",
      "volume": "15",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ajmg.b.30493",
      "author": "JD Buxbaum",
      "doi-asserted-by": "publisher",
      "first-page": "484",
      "journal-title": "Am J Med Genet B Neuropsychiatr Genet",
      "key": "BFejhg2008162_CR54",
      "unstructured": "Buxbaum JD, Cai G, Chaste P et al: Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 484–491.",
      "volume": "144",
      "year": "2007"
    },
    {
      "DOI": "10.1136/jmg.38.12.820",
      "author": "W Reardon",
      "doi-asserted-by": "publisher",
      "first-page": "820",
      "journal-title": "J Med Genet",
      "key": "BFejhg2008162_CR55",
      "unstructured": "Reardon W, Zhou XP, Eng C : A novel germline mutation of the PTEN gene in a patient with macrocephaly, ventricular dilatation, and features of VATER association. J Med Genet 2001; 38: 820–823.",
      "volume": "38",
      "year": "2001"
    },
    {
      "DOI": "10.1001/jama.294.19.2465",
      "author": "K Sweet",
      "doi-asserted-by": "publisher",
      "first-page": "2465",
      "journal-title": "JAMA",
      "key": "BFejhg2008162_CR56",
      "unstructured": "Sweet K, Willis J, Zhou XP et al: Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 2005; 294: 2465–2473.",
      "volume": "294",
      "year": "2005"
    },
    {
      "DOI": "10.1136/gut.2007.142927",
      "author": "WA van Hattem",
      "doi-asserted-by": "publisher",
      "first-page": "623",
      "issue": "5",
      "journal-title": "Gut",
      "key": "BFejhg2008162_CR57",
      "unstructured": "van Hattem WA, Brosens LA, de Leng WW et al: Large genomic deletions of Smad4, Bmpr1a and Pten in juvenile polyposis. Gut 2008; 57 (5): 623–627.",
      "volume": "57",
      "year": "2008"
    },
    {
      "DOI": "10.1056/NEJM200107193450301",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "publisher",
      "first-page": "159",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2008162_CR58",
      "unstructured": "Meijers-Heijboer H, van Geel B, van Putten WL et al: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 2001; 345: 159–164.",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1093/jnci/93.21.1633",
      "author": "LC Hartmann",
      "doi-asserted-by": "publisher",
      "first-page": "1633",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2008162_CR59",
      "unstructured": "Hartmann LC, Sellers TA, Schaid DJ et al: Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 2001; 93: 1633–1637.",
      "volume": "93",
      "year": "2001"
    },
    {
      "DOI": "10.1093/jnci/dji372",
      "author": "B Fisher",
      "doi-asserted-by": "publisher",
      "first-page": "1652",
      "journal-title": "J Natl Cancer Inst",
      "key": "BFejhg2008162_CR60",
      "unstructured": "Fisher B, Costantino JP, Wickerham DL et al: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 2005; 97: 1652–1662.",
      "volume": "97",
      "year": "2005"
    },
    {
      "DOI": "10.1001/jama.295.23.joc60074",
      "author": "VG Vogel",
      "doi-asserted-by": "publisher",
      "first-page": "2727",
      "journal-title": "JAMA",
      "key": "BFejhg2008162_CR61",
      "unstructured": "Vogel VG, Costantino JP, Wickerham DL et al: Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006; 295: 2727–2741.",
      "volume": "295",
      "year": "2006"
    },
    {
      "author": "Y Shi",
      "first-page": "5027",
      "journal-title": "Cancer Res",
      "key": "BFejhg2008162_CR62",
      "unstructured": "Shi Y, Gera J, Hu L et al: Enhanced sensitivity of multiple myeloma cells containing PTEN mutations to CCI-779. Cancer Res 2002; 62: 5027–5034.",
      "volume": "62",
      "year": "2002"
    },
    {
      "DOI": "10.1073/pnas.171076798",
      "author": "MS Neshat",
      "doi-asserted-by": "publisher",
      "first-page": "10314",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2008162_CR63",
      "unstructured": "Neshat MS, Mellinghoff IK, Tran C et al: Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc Natl Acad Sci USA 2001; 98: 10314–10319.",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1677/erc.0.0080249",
      "author": "K Yu",
      "doi-asserted-by": "publisher",
      "first-page": "249",
      "journal-title": "Endocr Relat Cancer",
      "key": "BFejhg2008162_CR64",
      "unstructured": "Yu K, Toral-Barza L, Discafani C et al: mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer. Endocr Relat Cancer 2001; 8: 249–258.",
      "volume": "8",
      "year": "2001"
    },
    {
      "DOI": "10.1073/pnas.171060098",
      "author": "K Podsypanina",
      "doi-asserted-by": "publisher",
      "first-page": "10320",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2008162_CR65",
      "unstructured": "Podsypanina K, Lee RT, Politis C et al: An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice. Proc Natl Acad Sci USA 2001; 98: 10320–10325.",
      "volume": "98",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJMoa063564",
      "author": "JJ Bissler",
      "doi-asserted-by": "publisher",
      "first-page": "140",
      "journal-title": "N Engl J Med",
      "key": "BFejhg2008162_CR66",
      "unstructured": "Bissler JJ, McCormack FX, Young LR et al: Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358: 140–151.",
      "volume": "358",
      "year": "2008"
    },
    {
      "DOI": "10.1038/ncponc1112",
      "author": "DJ Marsh",
      "doi-asserted-by": "publisher",
      "first-page": "357",
      "journal-title": "Nat Clin Pract Oncol",
      "key": "BFejhg2008162_CR67",
      "unstructured": "Marsh DJ, Trahair TN, Martin JL et al: Rapamycin treatment for a child with germline PTEN mutation. Nat Clin Pract Oncol 2008; 5: 357–361.",
      "volume": "5",
      "year": "2008"
    },
    {
      "DOI": "10.1161/01.CIR.101.6.660",
      "author": "Y Fujio",
      "doi-asserted-by": "publisher",
      "first-page": "660",
      "journal-title": "Circulation",
      "key": "BFejhg2008162_CR68",
      "unstructured": "Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K : Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000; 101: 660–667.",
      "volume": "101",
      "year": "2000"
    },
    {
      "DOI": "10.33549/physiolres.930582",
      "author": "J Zdychova",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Physiol Res",
      "key": "BFejhg2008162_CR69",
      "unstructured": "Zdychova J, Komers R : Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiol Res 2005; 54: 1–16.",
      "volume": "54",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-0917",
      "author": "SY Sun",
      "doi-asserted-by": "publisher",
      "first-page": "7052",
      "journal-title": "Cancer Res",
      "key": "BFejhg2008162_CR70",
      "unstructured": "Sun SY, Rosenberg LM, Wang X et al: Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Cancer Res 2005; 65: 7052–7058.",
      "volume": "65",
      "year": "2005"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-05-2925",
      "author": "KE O'Reilly",
      "doi-asserted-by": "publisher",
      "first-page": "1500",
      "journal-title": "Cancer Res",
      "key": "BFejhg2008162_CR71",
      "unstructured": "O'Reilly KE, Rojo F, She QB et al: mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt. Cancer Res 2006; 66: 1500–1508.",
      "volume": "66",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.onc.1209990",
      "author": "X Wan",
      "doi-asserted-by": "publisher",
      "first-page": "1932",
      "journal-title": "Oncogene",
      "key": "BFejhg2008162_CR72",
      "unstructured": "Wan X, Harkavy B, Shen N, Grohar P, Helman LJ : Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism. Oncogene 2007; 26: 1932–1940.",
      "volume": "26",
      "year": "2007"
    },
    {
      "DOI": "10.1371/journal.pmed.0050008",
      "author": "TF Cloughesy",
      "doi-asserted-by": "publisher",
      "first-page": "e8",
      "journal-title": "PLoS Med",
      "key": "BFejhg2008162_CR73",
      "unstructured": "Cloughesy TF, Yoshimoto K, Nghiemphu P et al: Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma. PLoS Med 2008; 5: e8.",
      "volume": "5",
      "year": "2008"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-07-2154",
      "author": "QW Fan",
      "doi-asserted-by": "publisher",
      "first-page": "7960",
      "journal-title": "Cancer Res",
      "key": "BFejhg2008162_CR74",
      "unstructured": "Fan QW, Cheng CK, Nicolaides TP et al: A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma. Cancer Res 2007; 67: 7960–7965.",
      "volume": "67",
      "year": "2007"
    },
    {
      "DOI": "10.1200/jco.2008.26.15_suppl.3510",
      "doi-asserted-by": "crossref",
      "key": "BFejhg2008162_CR75",
      "unstructured": "Papadopoulos KP, Markman B, Tabernero J et al: A phase I dose-escalation study of the safety, parmacokinetics (PK), and pharmacodynamics (PD) of a novel PI3K inhibitor, XL765, administered orally to patients (pts) with advanced solid tumors. J Clin Oncol 2008; 26: (20 May suppl; abstract 3510)."
    },
    {
      "DOI": "10.1073/pnas.0500617102",
      "author": "A Beilina",
      "doi-asserted-by": "publisher",
      "first-page": "5703",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "BFejhg2008162_CR76",
      "unstructured": "Beilina A, Van Der Brug M, Ahmad R et al: Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability. Proc Natl Acad Sci USA 2005; 102: 5703–5708.",
      "volume": "102",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.onc.1204608",
      "author": "M Unoki",
      "doi-asserted-by": "publisher",
      "first-page": "4457",
      "journal-title": "Oncogene",
      "key": "BFejhg2008162_CR77",
      "unstructured": "Unoki M, Nakamura Y : Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene 2001; 20: 4457–4465.",
      "volume": "20",
      "year": "2001"
    }
  ],
  "reference-count": 77,
  "references-count": 77,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2008162"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "PTEN hamartoma tumor syndromes"
  ],
  "type": "journal-article",
  "volume": "16"
}